Contraceptives Market Analysis

  • Report ID: 4635
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Contraceptives Market Analysis

End-user (Homecare, Clinics, Hospitals, Pharmacies)

The global contraceptives market is segmented and analyzed for demand and supply by end-user into home care, clinics, hospitals, and pharmacies. Out of these, the pharmacies segment is anticipated to hold the largest market size by the end 0f 2037 on account of the rising manufacturing rate of birth control pills and availability of a wide range of contraceptive options to buy from retail pharmacies without a prescription such as condoms, spermicides, and intrauterine devices. As per the statistical estimations, about 34 million Americans used condoms during intercourse to prevent pregnancy in 2020. Also, the collaboration of pharmacies with hospitals to distribute contraceptives is anticipated to fuel the revenue generation of the segment. Furthermore, the presence of pharmacies in every region along with easy availability makes pharmacies an ideal option to buy contraceptives. On the other hand, the hospital segment is also projected to grow steadily in the assessment period. The rising number of gynecologists present in hospital settings prescribing contraceptives is a major factor for segment growth. Also, the availability of safe and reliable contraceptive devices in hospitals under doctors’ guidance is forecasted to bring a favorable chance for segment growth.

Gender (Male, Female)

The global contraceptives market is also segmented and analyzed for demand and supply by gender into male and female. Out of these two, the male segment is anticipated to grow with a significant CAGR in the forecast period. The major factor attributed to segment growth is the availability of male contraceptives in the market. Male condoms are considered to be the most used and easily accessible contraceptives. A recent report of 2020 stated that over 450 million condoms are sold every year in the United States.

Our in-depth analysis of the global market includes the following segments:

                  By Product Type

  • Drugs
  • Devices
  • Condoms
  • Vaginal Rings
  • Implants
  • Injectables

                 By Age

  • 15-44 Years
  • Above 44 Years

                 By Gender

  • Male
  • Female

                  By End-User

  • Homecare
  • Clinics
  • Hospitals
  • Pharmacies
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4635
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of contraceptives is estimated at USD 30.9 billion.

The contraceptives market size was over USD 29.44 billion in 2024 and is projected to cross USD 64.16 billion by the end of 2037, witnessing more than 6.3% CAGR during the forecast period i.e., between 2025-2037. Growing disposable income and rising world population along with elevating risks of abortion will boost the market growth.

North America is anticipated to hold largest industry share by 2037, driven by rising demand for contraceptive pills and growing awareness among people on various contraceptive options such as female condom, and injectable contraceptives.

The major players in the market include Novartis Pharmaceutical Corporation, Agile Therapeutics, Inc., GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Piramal Group, Viatris Inc., Pfizer Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample